GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis

Mayo CALR mutation type classification guide using alpha helix propensity

(2018) Terra L. Lasho et al.   AMERICAN JOURNAL OF HEMATOLOGY

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis

(2018) Paola Guglielmelli et al.   JOURNAL OF CLINICAL ONCOLOGY

Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients

(2018) Ayalew Tefferi et al.   LEUKEMIA

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions

(2018) Ayalew Tefferi et al.   LEUKEMIA

Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis

(2017) A Tefferi et al.   LEUKEMIA

Does ruxolitinib prolong the survival of patients with myelofibrosis?

(2016) Francisco Cervantes et al.   BLOOD

Improved survival in patients with CALR1 compared to CALR2 mutated primary myelofibrosis: a meta-analysis

(2016) Hampig Raphael Kourie et al.   BRITISH JOURNAL OF HAEMATOLOGY

Allogeneic Hematopoietic Stem-Cell Transplantation for Myelofibrosis: A Practical Review

(2016) Nosha Farhadfar et al.   Journal of Oncology Practice

Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis

(2015) P Guglielmelli et al.   Blood Cancer Journal

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

(2014) A. Tefferi et al.   BLOOD

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

(2014) A. Tefferi et al.   BLOOD

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis

(2014) A Pardanani et al.   LEUKEMIA

Mutations and prognosis in primary myelofibrosis

(2013) A M Vannucchi et al.   LEUKEMIA

DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

(2010) Naseema Gangat et al.   JOURNAL OF CLINICAL ONCOLOGY

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

(2009) F. Passamonti et al.   BLOOD

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

(2008) F. Cervantes et al.   BLOOD